Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biognosys
Schlieren, Zurich, Switzerland
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
Biognosys provides patented, high-throughput, deep-coverage proteomics services and technologies, empowering biomarker and drug target discovery, clinical trial analytics, and precision proteome measurement for pharma, biotech, and academia. They support customers across preclinical, translational, and clinical research, integrating proteomic, genomic, and health record data streams for advanced biomedical analysis.
- Therapeutic areas
- Other
- Modalities
- BiologicProteinPeptidesBiomarker assay (technology platform, not a therapeutic modality)Mass spectrometry-based proteomics
- Industry
- Drug Discovery Services
02
Partnerships
Evotec (drug discovery collaboration)Alamar (NULISA assay integration, scientific partnership)Various pharmaceutical and biotechnology companies (CRO clients, undisclosed)Academic partners globally (ETH Zurich, others)
Beyond the preview
Go deeper on Biognosys.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biognosys.